Timber Pharmaceuticals, Inc. (‘Timber’ or the ‘Company’) announced that Chief Executive Officer John Koconis has been appointed as Chairman of the Board of Directors. The Company also announced that Edward J. Sitar has been appointed as Lead Independent Director of the Board and David Cohen, M.D., will serve as Chair of the Company’s new Science and Technology Committee. Mr. Koconis has served as Chief Executive Officer of Timber since 2019. Mr. Koconis previously held leadership positions with LEO Pharma, Sanofi/Genzyme, and Castle Creek Pharmaceuticals. Mr. Sitar has served as a director on its Board since May 2020. Mr. Sitar has had extensive financial leadership experience. Dr. Cohen has also served on the Timber Board of Directors since 2020. In addition to his scientific credentials Dr. Cohen has also served on numerous public and private company boards.